Asahi Kasei Bioprocess America, Inc. is a global player in the biopharmaceutical industry, focusing on ensuring the safety and efficiency of biologics production. The company's slogan "Pioneering Biologics Safety and Manufacturing Efficiency" reflects its commitment to delivering innovative and reliable bioprocess consumables, equipment, and scientific support services.
At the core of Asahi Kasei Bioprocess America, Inc.'s portfolio are the Planova™ virus removal filters. These filters, introduced in 1989, were the world's first hollow fiber filters designed specifically for removing viruses from biotherapeutic drug products, ensuring the viral safety of biopharmaceutical drug products through their consistent and high-quality performance. The company leverages its 30 years of experience to provide customers with products, services, and expertise that exceed expectations, thereby establishing trust and reliability in the market.
In addition to virus filtration, Asahi Kasei Bioprocess America, Inc. manufactures downstream equipment, including technology platforms for chromatography, inline buffer formulation, and oligonucleotide synthesis. These bioprocessing systems, columns, and automation solutions are dedicated to advancing Good Manufacturing Practice (GMP) manufacturing of critical drug substances worldwide. The company's cutting-edge technology spans across diverse therapeutic modalities, ranging from small molecule pharmaceuticals to next-generation oligonucleotide therapeutics, demonstrating its versatility and adaptability within the industry.
With a founding year of 1989, Asahi Kasei Bioprocess America, Inc. operates within the Biotechnology and Manufacturing industries. Although specific details about the company's headquarters, last investment, and investors are not available, its extensive expertise and focus on biologics safety and manufacturing efficiency position it as a significant player in the biopharmaceutical sector, poised for potential growth and impact within the industry.
There is no investment information
No recent news or press coverage available for Asahi Kasei Bioprocess America, Inc..